Zhou Yu, Feng Xiao, Liu Ya-ling, Ye Shi-cai, Wang Hao, Tan Wen-kai, Tian Ting, Qiu Yu-mei, Luo He-sheng
Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China ; Department of Gastroenterology, The Affiliated Hospital of Guangdong Medical College, Zhanjiang, Guangdong Province, China.
PLoS One. 2013 Nov 29;8(11):e81203. doi: 10.1371/journal.pone.0081203. eCollection 2013.
Colorectal carcinoma (CRC) is one of the leading causes of cancer-related mortality worldwide. MicroRNAs (miRNAs, miRs) play important roles in carcinogenesis. MiR-126 has been shown to be down-regulated in CRC. In this study, we identified the potential effects of miR-126 on some important biological properties of CRC cells and clarified the regulation of insulin receptor substrate 1 (IRS-1) and its possible signaling pathway by miR-126.
The effect of miR-126 on IRS-1, AKT, and ERK1/2 expression was assessed in the CRC cell lines HT-29 and HCT-116 with a miR-126 mimic or inhibitor to increase or decrease miR-126 expression. Furthermore, the roles of miR-126 in regulation of the biological properties of CRC cells were analyzed with miR-126 mimic or inhibitor-transfected cells. The 3'-untranslated region (3'-UTR) of IRS-1 regulated by miR-126 was analyzed by using a dual-luciferase reporter assay.
We found that IRS-1 is the functional downstream target of miR-126 by directly targeting the 3'-UTR of IRS-1. Endogenous miR-126 and exogenous miR-126 mimic inhibited IRS-1 expression. Furthermore, gain-of-function or loss-of-function studies showed that over-expression of miR-126 down-regulated IRS-1, suppressed AKT and ERK1/2 activation, CRC cells proliferation, migration, invasion, and caused cell cycle arrest, but had no effect on cell apoptosis. Knockdown of miR-126 promoted these processes in HCT-116 cells and promoted AKT and ERK1/2 activation by up-regulating the expression of the IRS-1 protein.
MiR-126 may play roles in regulation of the biological behavior of CRC cells, at least in part, by targeting IRS-1 via AKT and ERK1/2 signaling pathways.
结直肠癌(CRC)是全球癌症相关死亡的主要原因之一。微小RNA(miRNA,miR)在肿瘤发生过程中发挥重要作用。已有研究表明,miR-126在CRC中表达下调。在本研究中,我们确定了miR-126对CRC细胞某些重要生物学特性的潜在影响,并阐明了miR-126对胰岛素受体底物1(IRS-1)的调控及其可能的信号通路。
使用miR-126模拟物或抑制剂增加或降低miR-126表达,评估其对CRC细胞系HT-29和HCT-116中IRS-1、AKT和ERK1/2表达的影响。此外,用转染了miR-126模拟物或抑制剂的细胞分析miR-126在调控CRC细胞生物学特性中的作用。通过双荧光素酶报告基因检测分析miR-126调控的IRS-1的3'-非翻译区(3'-UTR)。
我们发现IRS-1是miR-126的功能性下游靶点,miR-126直接靶向IRS-1的3'-UTR。内源性miR-126和外源性miR-126模拟物均抑制IRS-1表达。此外,功能获得或功能丧失研究表明,miR-126过表达下调IRS-1,抑制AKT和ERK1/2激活、CRC细胞增殖、迁移、侵袭,并导致细胞周期停滞,但对细胞凋亡无影响。敲低miR-126可促进HCT-116细胞中的这些过程,并通过上调IRS-1蛋白表达促进AKT和ERK1/2激活。
miR-126可能至少部分通过AKT和ERK1/2信号通路靶向IRS-1来调控CRC细胞的生物学行为。